MedTrace Logo

A Study to Investigate the Effect of SB-705498 on Chronic Cough

NCT01476098 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 21

Last updated 2016-12-01

No results posted yet for this study

Summary

This study is designed to loook at the affect of oral SB-705498 on cough following an inhaled capsaicin challenge

Conditions

  • Rhinitis

Interventions

DRUG

Placebo

SB-705498 placebo

DRUG

SB-705498

400 or 600mg oral SB-705498

Sponsors & Collaborators

Principal Investigators

  • GSK Clinical Trials · GlaxoSmithKline

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-04-30
Primary Completion
2011-12-31
Completion
2012-01-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Drugs
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01476098 on ClinicalTrials.gov